Agios Pharm Stock Technical Analysis
| AGIO Stock | USD 27.71 0.58 2.14% |
As of the 11th of February 2026, Agios Pharm shows the Risk Adjusted Performance of (0.01), standard deviation of 7.27, and Mean Deviation of 3.11. Agios Pharm technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Agios Pharm Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Agios, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AgiosAgios Pharm's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Agios Pharm Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 36.63 | Buy | 9 | Odds |
Most Agios analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Agios stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Agios Pharm, talking to its executives and customers, or listening to Agios conference calls.
Will Biotechnology sector continue expanding? Could Agios diversify its offerings? Factors like these will boost the valuation of Agios Pharm. If investors know Agios will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Agios Pharm data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (7.01) | Revenue Per Share | Quarterly Revenue Growth 0.437 | Return On Assets | Return On Equity |
Agios Pharm's market price often diverges from its book value, the accounting figure shown on Agios's balance sheet. Smart investors calculate Agios Pharm's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Agios Pharm's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Agios Pharm's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Agios Pharm represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Agios Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Agios Pharm 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Agios Pharm's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Agios Pharm.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Agios Pharm on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Agios Pharm or generate 0.0% return on investment in Agios Pharm over 90 days. Agios Pharm is related to or competes with Denali Therapeutics, Recursion Pharmaceuticals, Beam Therapeutics, Arcus Biosciences, Cogent Biosciences, Immunitybio, and Galapagos. Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the f... More
Agios Pharm Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Agios Pharm's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Agios Pharm upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 56.88 | |||
| Value At Risk | (3.94) | |||
| Potential Upside | 5.99 |
Agios Pharm Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Agios Pharm's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Agios Pharm's standard deviation. In reality, there are many statistical measures that can use Agios Pharm historical prices to predict the future Agios Pharm's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (1.07) | |||
| Treynor Ratio | (0.17) |
Agios Pharm February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.16) | |||
| Mean Deviation | 3.11 | |||
| Coefficient Of Variation | (3,623) | |||
| Standard Deviation | 7.27 | |||
| Variance | 52.89 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (1.07) | |||
| Treynor Ratio | (0.17) | |||
| Maximum Drawdown | 56.88 | |||
| Value At Risk | (3.94) | |||
| Potential Upside | 5.99 | |||
| Skewness | (5.01) | |||
| Kurtosis | 37.55 |
Agios Pharm Backtested Returns
Agios Pharm secures Sharpe Ratio (or Efficiency) of -0.0497, which signifies that the company had a -0.0497 % return per unit of risk over the last 3 months. Agios Pharm exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Agios Pharm's Mean Deviation of 3.11, risk adjusted performance of (0.01), and Standard Deviation of 7.27 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.21, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Agios Pharm will likely underperform. At this point, Agios Pharm has a negative expected return of -0.37%. Please make sure to confirm Agios Pharm's skewness, and the relationship between the total risk alpha and rate of daily change , to decide if Agios Pharm performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.22 |
Weak reverse predictability
Agios Pharm has weak reverse predictability. Overlapping area represents the amount of predictability between Agios Pharm time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Agios Pharm price movement. The serial correlation of -0.22 indicates that over 22.0% of current Agios Pharm price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.22 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.44 |
Agios Pharm technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Agios Pharm Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Agios Pharm across different markets.
About Agios Pharm Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Agios Pharm on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Agios Pharm based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Agios Pharm price pattern first instead of the macroeconomic environment surrounding Agios Pharm. By analyzing Agios Pharm's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Agios Pharm's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Agios Pharm specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 38.24 | 41.09 | 36.98 | 35.79 | PTB Ratio | 1.53 | 1.21 | 1.39 | 1.32 |
Agios Pharm February 11, 2026 Technical Indicators
Most technical analysis of Agios help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Agios from various momentum indicators to cycle indicators. When you analyze Agios charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.16) | |||
| Mean Deviation | 3.11 | |||
| Coefficient Of Variation | (3,623) | |||
| Standard Deviation | 7.27 | |||
| Variance | 52.89 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (1.07) | |||
| Treynor Ratio | (0.17) | |||
| Maximum Drawdown | 56.88 | |||
| Value At Risk | (3.94) | |||
| Potential Upside | 5.99 | |||
| Skewness | (5.01) | |||
| Kurtosis | 37.55 |
Agios Pharm February 11, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Agios stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 58,798 | ||
| Daily Balance Of Power | 0.35 | ||
| Rate Of Daily Change | 1.02 | ||
| Day Median Price | 26.89 | ||
| Day Typical Price | 27.16 | ||
| Price Action Indicator | 1.12 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agios Pharm. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Will Biotechnology sector continue expanding? Could Agios diversify its offerings? Factors like these will boost the valuation of Agios Pharm. If investors know Agios will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Agios Pharm data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (7.01) | Revenue Per Share | Quarterly Revenue Growth 0.437 | Return On Assets | Return On Equity |
Agios Pharm's market price often diverges from its book value, the accounting figure shown on Agios's balance sheet. Smart investors calculate Agios Pharm's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Agios Pharm's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Agios Pharm's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Agios Pharm represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Agios Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.